Scottish blood service secures prion-filter patent:
This article was originally published in Clinica
Executive Summary
The European Patent Office has granted the Scottish National Blood Transfusion Service (SNBTS) a patent for its technique for removing abnormal prion protein from solution containing biological products. The "depth filtration" technique involved has "no unacceptable effects on the nature or biological activity of the product", says the SNBTS, which developed the method to support the manufacture of plasma products, such as albumin and immune globulin. "Although we have not used UK plasma for fractionation since 1998, this technology is a welcome additional safety measure that can be applied worldwide," says the SNBTS. It believes that the technology has a "wide range of applications, not only in plasma products, but also in other bio-processing technologies that require risk reduction, such as cell culture media". The announcement coincides with the publication of the UK's 2003 Serious Hazards of Transfusion report (see Clinica No 1117), which features the first suspected case of transfusion-transmitted vCJD, identified following the death of a transfusion recipient.
You may also be interested in...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.